3
Registered trials
2
Recruiting
1
Completed trials
4
Countries active
0
Unique IMPs
100%
Results reported
100%
1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).
All trials
3 total-
Phase 1 Study of PYX-201 in Solid Tumors Recruiting
Showing 1–3 of 3 trials